vs
HUDSON TECHNOLOGIES INC（HDSN）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是HUDSON TECHNOLOGIES INC的1.6倍（$69.8M vs $44.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -19.4%，领先403.5%），HUDSON TECHNOLOGIES INC同比增速更快（28.2% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -17.5%）
哈德逊科技是总部位于美国的可持续制冷剂解决方案供应商，提供原生及回收再生制冷剂、制冷剂回收处理和合规支持服务，主要服务北美市场，核心客户覆盖暖通空调、商用制冷和工业冷却领域，助力客户向低全球变暖潜能值制冷剂转型。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
HDSN vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.6倍
$44.4M
营收增速更快
HDSN
高出7.0%
21.2%
净利率更高
RIGL
高出403.5%
-19.4%
两年增速更快
RIGL
近两年复合增速
-17.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.4M | $69.8M |
| 净利润 | $-8.6M | $268.1M |
| 毛利率 | 8.0% | 91.5% |
| 营业利润率 | -25.2% | 33.2% |
| 净利率 | -19.4% | 384.0% |
| 营收同比 | 28.2% | 21.2% |
| 净利润同比 | -236.6% | 1769.2% |
| 每股收益（稀释后） | $-0.19 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HDSNRIGL
| Q4 25 | $44.4M | $69.8M | ||
| Q3 25 | $74.0M | $69.5M | ||
| Q2 25 | $72.8M | $101.7M | ||
| Q1 25 | $55.3M | $53.3M | ||
| Q4 24 | $34.6M | $57.6M | ||
| Q3 24 | $61.9M | $55.3M | ||
| Q2 24 | $75.3M | $36.8M | ||
| Q1 24 | $65.3M | $29.5M |
净利润HDSNRIGL
| Q4 25 | $-8.6M | $268.1M | ||
| Q3 25 | $12.4M | $27.9M | ||
| Q2 25 | $10.2M | $59.6M | ||
| Q1 25 | $2.8M | $11.4M | ||
| Q4 24 | $-2.6M | $14.3M | ||
| Q3 24 | $7.8M | $12.4M | ||
| Q2 24 | $9.6M | $-1.0M | ||
| Q1 24 | $9.6M | $-8.2M |
毛利率HDSNRIGL
| Q4 25 | 8.0% | 91.5% | ||
| Q3 25 | 32.0% | 93.2% | ||
| Q2 25 | 31.3% | 95.6% | ||
| Q1 25 | 21.8% | 91.7% | ||
| Q4 24 | 16.7% | 89.9% | ||
| Q3 24 | 25.7% | 85.5% | ||
| Q2 24 | 30.0% | 92.4% | ||
| Q1 24 | 32.8% | 93.1% |
营业利润率HDSNRIGL
| Q4 25 | -25.2% | 33.2% | ||
| Q3 25 | 18.9% | 40.9% | ||
| Q2 25 | 17.5% | 60.1% | ||
| Q1 25 | 5.6% | 23.9% | ||
| Q4 24 | -9.4% | 28.9% | ||
| Q3 24 | 11.3% | 25.4% | ||
| Q2 24 | 17.0% | 1.2% | ||
| Q1 24 | 19.6% | -23.6% |
净利率HDSNRIGL
| Q4 25 | -19.4% | 384.0% | ||
| Q3 25 | 16.7% | 40.2% | ||
| Q2 25 | 14.0% | 58.6% | ||
| Q1 25 | 5.0% | 21.5% | ||
| Q4 24 | -7.4% | 24.9% | ||
| Q3 24 | 12.6% | 22.5% | ||
| Q2 24 | 12.7% | -2.8% | ||
| Q1 24 | 14.7% | -27.9% |
每股收益（稀释后）HDSNRIGL
| Q4 25 | $-0.19 | $14.11 | ||
| Q3 25 | $0.27 | $1.46 | ||
| Q2 25 | $0.23 | $3.28 | ||
| Q1 25 | $0.06 | $0.63 | ||
| Q4 24 | $-0.05 | $0.82 | ||
| Q3 24 | $0.17 | $0.70 | ||
| Q2 24 | $0.20 | $-0.06 | ||
| Q1 24 | $0.20 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $243.4M | $391.5M |
| 总资产 | $318.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资HDSNRIGL
| Q4 25 | $39.5M | $155.0M | ||
| Q3 25 | $89.7M | $137.1M | ||
| Q2 25 | $84.3M | $108.4M | ||
| Q1 25 | $81.0M | $77.1M | ||
| Q4 24 | $70.1M | $77.3M | ||
| Q3 24 | $56.5M | $61.1M | ||
| Q2 24 | $30.5M | $49.1M | ||
| Q1 24 | $10.6M | $49.5M |
总债务HDSNRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益HDSNRIGL
| Q4 25 | $243.4M | $391.5M | ||
| Q3 25 | $265.9M | $117.6M | ||
| Q2 25 | $254.8M | $81.9M | ||
| Q1 25 | $246.8M | $18.6M | ||
| Q4 24 | $245.8M | $3.3M | ||
| Q3 24 | $253.9M | $-14.6M | ||
| Q2 24 | $248.7M | $-29.9M | ||
| Q1 24 | $238.6M | $-31.7M |
总资产HDSNRIGL
| Q4 25 | $318.6M | $513.6M | ||
| Q3 25 | $338.9M | $242.5M | ||
| Q2 25 | $317.9M | $206.7M | ||
| Q1 25 | $307.9M | $176.0M | ||
| Q4 24 | $302.7M | $164.0M | ||
| Q3 24 | $309.4M | $139.4M | ||
| Q2 24 | $300.9M | $128.4M | ||
| Q1 24 | $294.2M | $126.5M |
负债/权益比HDSNRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-33.7M | — |
| 自由现金流率自由现金流/营收 | -75.8% | — |
| 资本支出强度资本支出/营收 | 2.5% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-8.2M | — |
8季度趋势，按日历期对齐
经营现金流HDSNRIGL
| Q4 25 | $-32.5M | $22.0M | ||
| Q3 25 | $8.8M | $24.0M | ||
| Q2 25 | $6.4M | $30.5M | ||
| Q1 25 | $14.2M | $-893.0K | ||
| Q4 24 | $20.7M | $14.5M | ||
| Q3 24 | $30.3M | $21.7M | ||
| Q2 24 | $41.8M | $302.0K | ||
| Q1 24 | $-933.0K | $-5.0M |
自由现金流HDSNRIGL
| Q4 25 | $-33.7M | — | ||
| Q3 25 | $6.7M | — | ||
| Q2 25 | $5.9M | — | ||
| Q1 25 | $12.7M | — | ||
| Q4 24 | $19.2M | — | ||
| Q3 24 | $28.6M | — | ||
| Q2 24 | $40.6M | — | ||
| Q1 24 | $-1.9M | — |
自由现金流率HDSNRIGL
| Q4 25 | -75.8% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 8.2% | — | ||
| Q1 25 | 23.0% | — | ||
| Q4 24 | 55.3% | — | ||
| Q3 24 | 46.2% | — | ||
| Q2 24 | 54.0% | — | ||
| Q1 24 | -2.9% | — |
资本支出强度HDSNRIGL
| Q4 25 | 2.5% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.5% | — |
现金转化率HDSNRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 0.71× | 0.86× | ||
| Q2 25 | 0.63× | 0.51× | ||
| Q1 25 | 5.13× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 3.88× | 1.75× | ||
| Q2 24 | 4.36× | — | ||
| Q1 24 | -0.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HDSN
| Products | $43.1M | 97% |
| Services | $1.3M | 3% |
RIGL
暂无分部数据
